The ADVIFLAG study investigates a new treatment for lung infections.
ADVIFLAG is part of the FAIR project, a European project funded by Horizon 2020.
In this study, the researchers want to learn about people’s attitudes towards a new treatment for lung infections such as pneumonia. They want to understand what might influence people’s perspectives on this new treatment and what could be changed to make the treatment as suitable as possible for patients and carers.
In this study the treatment is taken along with antibiotics. This treatment is called flagellin. Flagellin is taken in the form of an aerosol which is a cloud of very small droplets of liquid that you breathe in.
If you take part in this study, you will not be given flagellin, the treatment. You will be asked to fill in a survey about the treatment. You will be asked to imagine that you have been given the treatment. The questions will ask about:
The survey will take around 20-30 minutes.
If you take part in this study, you will not be administering flagellin, the treatment. You will be asked to fill in a survey about the treatment and how it is administered. You will be asked to imagine that you have prescribed or given the treatment to a patient. The questions will ask about:
The survey will take around 15 minutes.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.